The theoretical diversity of the human adaptive immune system is astronomically large. Through V(D)J recombination, the body can generate an estimated $10^{13}$ to $10^{18}$ unique T-cell receptors (TCRs) and B-cell receptors (BCRs). Given this vast combinatorial space, classical immunology long assumed that two individuals responding to the same pathogen would deploy entirely unique, stochastic sets of receptors—an immune response as individualized as a fingerprint.
Yet, genomic sequencing has revealed a striking paradox: unrelated individuals exposed to the same antigen frequently develop identical or near-identical receptor sequences. This phenomenon, known as a public repertoire or convergent immune response, suggests that the adaptive immune system is far more predictable and stereotyped than its genetic potential implies.
To understand why the immune system converges on shared solutions, we must look beyond full-length sequence matching and examine the underlying structural constraints and sequence motifs that govern antigen recognition.
Sequence-Level Convergence and Shared Motifs
The most visible form of convergence occurs at the primary sequence level, particularly within the hypervariable Complementarity-Determining Region 3 (CDR3), which directly contacts the antigen. When a specific pathogen exerts selective pressure, the immune systems of different individuals often independently arrive at identical genetic sequences.
For instance, Yongsi Wang et al. demonstrated in Comprehensive analysis of TCR repertoire of COVID-19 patients in different infected stage that certain infections drive the immune system toward highly stereotyped responses, allowing identical TCR sequences to appear across distinct cohorts. Similarly, Zhihua Wu et al. identified shared public TCR sequences across unrelated patients responding to human cytomegalovirus (HCMV) in Relationship between T-cell receptor beta chain sequences and human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. These public clonotypes are not transient; Louise F. Risnes et al. showed in Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease that these shared structural configurations can persist stably in the body for over 25 years.
Why do these identical sequences recur? Sequence-level convergence is driven by two main factors:
- Biased Generation Probabilities: Certain V(D)J recombination events are mechanistically favored and more likely to occur across populations by chance.
- Functional Selection of Motifs: The immune system exhibits degeneracy, meaning many distinct receptor sequences can recognize the same target by sharing short, conserved amino acid patterns rather than entire identical chains.
By analyzing gluten-specific TCRs in Comprehensive Analysis of CDR3 Sequences in Gluten-Specific T-Cell Receptors Reveals a Dominant R-Motif and Several New Minor Motifs, Shiva Dahal‐Koirala et al. discovered that immune recognition is frequently dominated by these conserved sub-sequence motifs, such as a highly prevalent "R-motif" in the CDR3 region. Because immune specificity is encoded in these short, conserved blocks, full-sequence matching often misses the broader pattern of convergence.
To capture this hidden layer of sharing, researchers focus on short sequence fragments. Niclas Thomas et al. in Tracking global changes induced in the CD4 T-cell receptor repertoire by immunization with a complex antigen using short stretches of CDR3 protein sequence and Yuxin Sun et al. in Specificity, Privacy, and Degeneracy in the CD4 T Cell Receptor Repertoire Following Immunization proved that analyzing short amino acid patterns (such as three-amino-acid triplets) can successfully identify antigen-specific responses across diverse individuals. Building on this, Mattia Cinelli et al. demonstrated in Feature selection using a one dimensional naïve Bayes' classifier increases the accuracy of support vector machine classification of CDR3 repertoires that machine learning models can accurately classify immune repertoires by filtering for these short, convergent sub-sequence motifs.
The 3D Structural Bottleneck
While sequence motifs explain part of the phenomenon, the true driver of immune convergence is physical and structural. Sequence diversity vastly overstates functional diversity. In reality, the human immune system relies on a highly conservative set of three-dimensional structural folds to solve binding challenges.
[Astronomical Sequence Space] (Millions of unique CDR3 sequences)
│
▼
[Structural Bottleneck] (Highly conservative set of 3D backbone geometries)
│
▼
[Epitope Engagement] (Convergent paratopes binding the same target)
Using the Structural Annotation of Antibodies (SAAB) pipeline in Structurally Mapping Antibody Repertoires, Konrad Krawczyk et al. demonstrated that despite the theoretical capacity to produce billions of distinct sequences, antibodies fold into a remarkably limited repertoire of backbone geometries. This structural toolkit is shared across populations; Aleksandr Kovaltsuk et al. found in Structural Diversity of B-Cell Receptor Repertoires along the B-cell Differentiation Axis in Humans and Mice that naive B-cell populations across different individuals exhibit a highly conserved set of shared antibody geometries before antigen exposure begins tailoring them.
Because the physical constraints of binding a specific epitope dictate a precise 3D shape, entirely distinct genetic lineages can arrive at the exact same physical solution—a phenomenon known as epitope convergence. As Aleksandr Kovaltsuk et al. argued in How B-Cell Receptor Repertoire Sequencing Can Be Enriched with Structural Antibody Data, sequence-only analysis leaves researchers "functionally blind" to these similarities because different genetic pathways frequently achieve identical structural paratopes.
To bypass the limitations of sequence-based lineage tracking, Eve Richardson et al. developed a method called "paratyping" in A computational method for immune repertoire mining that identifies novel binders from different clonotypes, demonstrated by identifying anti-Pertussis toxoid antibodies. Instead of grouping antibodies by genetic ancestry, paratyping clusters them by their predicted 3D binding sites. This approach proved that antibodies from completely different genetic lineages can target the same epitope if they share conserved paratope residues, allowing researchers to "hop" across different genetic scaffolds to find functional equivalents.
This structural predictability is so robust that natural selection and artificial engineering often converge on the same molecular designs. In Looking for therapeutic antibodies in next-generation sequencing repositories, Konrad Krawczyk et al. discovered a substantial structural overlap between clinically engineered therapeutic antibodies and naturally occurring public sequences, particularly within the hypervariable CDR-H3 loop.
Evolutionary Universality and Clinical Engineering
The constraints that force immune systems to converge are not unique to humans; they represent a universal evolutionary blueprint. When facing identical biochemical challenges, different species often deploy identical structural solutions.
For example, Alexandra C. Willcox et al. showed in Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques that humans and macaques develop nearly identical antibody binding patterns and escape pathways when targeting highly conserved viral regions like the stem helix of the SARS-CoV-2 spike protein. On a broader evolutionary scale, Anne Debost‐Legrand et al. demonstrated in Evolutionary characterization of antiviral SAMD9/9L across kingdoms supports ancient convergence and lineage-specific adaptations that antiviral defense systems across kingdoms (bacteria and eukaryotes) utilize structurally identical protein domains to inhibit viral replication despite having negligible genetic sequence similarity.
Exploiting Convergence for Immunotherapy
Understanding that the immune response follows a predictable, shared architecture allows researchers to move away from purely personalized medicine toward standardized, "off-the-shelf" clinical interventions.
- Antibody Optimization: In therapeutic design, Yi-Chun Hsiao et al. demonstrated in Rapid affinity optimization of an anti-TREM2 clinical lead antibody by cross-lineage immune repertoire mining that mining parallel, independent B-cell lineages that share a common binding geometry allows researchers to exploit natural evolutionary experiments, rapidly identifying high-affinity variants for clinical leads.
- Shared Cancer Targets: While many tumor neoantigens are patient-specific, Jingcheng Wu et al. highlighted in TSNAdb v2.0: the updated version of tumor-specific neoantigen database that a subset of shared neoantigens occurs predictably across multiple individuals due to common driver mutations.
- Recurrent Isoforms and Viral Remnants: Beyond mutations, Zhongxiao Li et al. identified a panel of recurrent transcript isoforms across different patients with colorectal cancer in An isoform-resolution transcriptomic atlas of colorectal cancer from long-read single-cell sequencing. Similarly, Paola Bonaventura et al. showed in HERV-derived epitopes represent new targets for T-cell-based immunotherapies in ovarian cancer that ancient endogenous retroviral sequences (HERVs) integrated into the human genome are reactivated predictably in tumor cells.
Because these targets are recurrently produced across populations, they bypass the logistical hurdles of patient-specific manufacturing, providing a foundation for universal, population-wide immunotherapies. By shifting the focus from individual sequence variations to the shared structural rules of the immune system, the field can now predict, track, and engineer immune responses with unprecedented precision.
Key Foundational Work
Stochastic Hybrid System for Chemical Master Equation (2009) — contributed 3 concept elements to this direction.
Identification of Common Biological Pathways and Drug Targets Across Multiple Respiratory Viruses Based on Human Host Gene Expression Analysis (2012) — contributed 1 concept elements to this direction.